Summary & Overview
Back and Neck Procedures Except Spinal Fusion with MCC or Disc Device or Neurostimulator: Inpatient Reimbursement Overview
DRG 518 encompasses non‑fusion back and neck procedures without a Major Complication or Comorbidity or disc device or neurostimulator, covering decompressions and discectomies. This Diagnosis-Related Group matters for inpatient reimbursement because it groups cases by expected resource use and determines prospective payment under Medicare.
DRG 518 Overview
DRG 518 covers inpatient cases involving back and neck procedures other than spinal fusion that do not involve a Major Complication or Comorbidity or the placement of a disc device or neurostimulator. Typical procedures include decompression, discectomy without fusion, and other non‑fusion spinal operations focused on symptom relief or neural decompression. This Diagnosis-Related Group groups patients by resource use and clinical similarity, which directly affects Medicare reimbursement for hospitals. Accurate coding and documentation are central to assigning the correct Diagnosis-Related Group and capturing appropriate payment.
Clinical Trials
- Perioperative analgesia and enhanced recovery trials evaluating multimodal pain management protocols and nerve block strategies for patients undergoing non-fusion back and neck procedures (such as laminectomy, discectomy, or foraminotomy). These studies enroll adults admitted for acute surgical decompression or microdiscectomy and compare outcomes like opioid consumption, length of stay, perioperative complications, and early functional recovery between different analgesic regimens. Findings are directly relevant to providers and payers because effective perioperative protocols can reduce opioid use, shorten hospitalization, and lower immediate inpatient costs for this DRG.
- Comparative effectiveness trials comparing surgical approaches and minimally invasive techniques versus standard open procedures for degenerative spine pathology without fusion, often stratified by symptom severity and comorbidity burden. These trials study patient populations undergoing index back or neck procedures to assess operative time, intraoperative blood loss, complication rates, readmissions, and short-term functional improvement, helping determine which techniques offer the best balance of safety and resource use. Payers and hospital systems use these data to inform procedure selection, coding practice, and allocation of resources, as technique choice can materially affect inpatient utilization and downstream services.
- Post-discharge outcomes and care-pathway studies focused on rehabilitation, return-to-function, and readmission prevention for patients after non-fusion spine procedures, including evaluation of outpatient physical therapy timing, tele-rehabilitation, and criteria for safe discharge. These observational cohorts or pragmatic trials follow patients with varied baseline frailty and social support to measure 30- and 90-day readmissions, durable pain relief, and need for additional interventions. This research matters to providers and payers because optimized post-discharge pathways can reduce costly readmissions and downstream procedures, improve patient-reported outcomes, and impact bundled payment performance for episodes that include this DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.